Clinical trial
Multi-center Study on Therapy-oriented Molecular Subtyping of Hepatocellular Carcinoma
NCT03668158 is registered in ClinicalTrials.gov with Zhejiang University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-center Study on Therapy-oriented Molecular Subtyping of Hepatocellular Carcinoma
- Lead sponsor
- Zhejiang University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 20, 2018
- Completion date
- July 1, 2020
- Enrollment
- 500 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma